Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-27 @ 12:15 PM
Study NCT ID:
NCT05925803
Status:
RECRUITING
Last Update Posted:
2025-11-21
First Post:
2023-06-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2026-10-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-02
First Submit QC Date:
None
Study First Post Date:
2023-06-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-11-21
Last Update Post Date Type:
ESTIMATED